sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Acute Lung Injury Market Scope And Analysis

  • Report Code : TIPRE00025718
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 102
Buy Now

Asia Pacific Acute Lung Injury Market Analysis and Scope (2022 to 2028)

Buy Now

Asia Pacific Acute Lung Injury Market Report Asia Pacific Acute Lung Injury Market Size and Share Asia Pacific Acute Lung Injury Market Scope and Analysis

Asia Pacific Acute Lung Injury Market Report Scope

Report Attribute Details
Market size in 2021 US$ 122.16 Million
Market Size by 2028 US$ 174.61 Million
Global CAGR (2021 - 2028) 5.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Therapy
  • Mechanical Ventilation
  • Fluid Management
  • Pharmacotherapy
  • Adjunctive Procedures
By End User
  • Hospitals
  • Ambulatory Surgery Centers
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Angion
  • GlaxoSmithKline Plc
  • ReAlta Life Sciences Inc
  • Stemedica Cell Technologies Inc
  • Windtree Therapeutics Inc